EWM
ONC

Empirical Wealth Management’s BeOne Medicines Ltd ONC Stock Holding History

Empirical Wealth Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Buy
940
+42
+5% +$12.4K ﹤0.01% 900
2026
Q1 		$267K Buy
898
+106
+13% +$34.3K ﹤0.01% 842
2025
Q4 		$241K Buy
+792
New +$259K ﹤0.01% 791

Other funds holding ONC

AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Empirical Wealth Management's ONC Position: Q2 2026 in Review

Empirical Wealth Management increased its BeOne Medicines Ltd (ONC) stake by 4.7% in Q2 2026, buying an estimated $12.4K and bringing the position to 940 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #900.

Empirical Wealth Management first reported a position in ONC in Q4 2025 and has held it in 3 quarters since. 66 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Empirical Wealth Management held 940 shares of BeOne Medicines Ltd worth $268K as of Q2 2026.
  • Empirical Wealth Management bought 42 BeOne Medicines Ltd shares in Q2 2026, an estimated $12.4K.
  • BeOne Medicines Ltd made up ﹤0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #900 holding.
  • Empirical Wealth Management first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 3 quarters since.
  • 66 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.